Direct to Consumer Testing Market Size, Trends & Growth Opportunity By Test Type (Carrier Screening Tests, Genetic Health Risk (GHR) Tests), By Application (Cancer Diagnosis, Cardiovascular Disease Diagnosis, Genetic Disease Diagnosis), By Region and Fore

Global Direct to Consumer Testing Market Size, Trends and Growth Opportunity By Test Type (Less than 100 ml, 100-250ml, 251-500 ml, More than 500 ml), By Technology Type (Necked In, Shaped Wall, Straight Wall), By Sample Type (Cosmetics & Personal Care, Household Products, Automotive/Industrial, Others), By Application (Cosmetics & Personal Care, Household Products, Automotive/Industrial, Others), By Region and Forecast Till 2027.

Global Direct to Consumer Testing Market

Market Overview

Global Direct to Consumer Testing Market valued at USD 1.2 Billion in 2021 which is expected to reach at 3.2 Billion around 13.4% CAGR during 2022 to 2027.

Companies create and provide direct to consumer testing to consumers without the use of a healthcare third party professional. The cost of genetic testing kits is lower when purchased directly from manufacturers than when acquired from a healthcare provider. The direct-to-consumer testing market is predicted to have significant growth during this projection period because to the increased burden of various diseases, including cancer and cardiovascular system diseases. Furthermore, it is projected that throughout this projection period, the demand for ancestral DNA testing would rise, which will serve as further evidence of the growth of the global direct to consumer testing market. An rise in product innovation launches and an expansion of competitor portfolios will both assist the global direct-to-consumer testing market.

Market Drivers

The increase in public awareness is one of the main reasons anticipated to propel the direct-to-consumer (DTC) genetic testing market's growth during the forecast period. The direct-to-consumer (DTC) genetic testing industry is also expected to grow as a result of the rise in income levels in developing nations. On the other hand, the expansion of the direct-to-consumer (DTC) genetic testing industry in the timeframe period is predicted to be hampered by the rise in the price of DTC genetic testing.

Market Restraints

The worldwide direct to consumer testing market is anticipated to face significant challenges due to the lack of awareness regarding genetic testing in underdeveloped nations. Additionally, concerns over genetic privacy will restrain the expansion of the worldwide direct-to-consumer testing business.

Market Segmentation

Global Direct to Consumer Testing Market is segmented into test type, technology type, sample type and application. By test type it is segmented into Carrier Screening Tests, Genetic Health Risk (GHR) Tests, Pharmacogenetics Tests, Cancer Predisposition Tests, Low Risk General Wellness Tests, Ancestry Tests, Paternity Testing, and Cancer Susceptibility Tests. By technology type it segmented into SNP-Chip Genotyping, Whole Genome Sequencing, Next-Generation Sequencing and Sanger Sequencing. By sample type it is segmented into sample type such as Saliva Sample, and Blood Sample. By application it is segmented into Cancer Diagnosis, Cardiovascular Disease Diagnosis, and Genetic Disease Diagnosis.

Regional Analysis

The Direct to Consumer Testing market segmented into five regions North America, Europe, Latin America, Asia Pacific, Middle East and Africa. The direct-to-consumer (DTC) genetic testing business is dominated by North America due to a change in public attitudes around genetic testing. The direct-to-consumer (DTC) genetic testing market will expand in the area during the forecast period as a result of the increase in spending as well. Due to a surge in health awareness, Asia-Pacific is expected to have considerable growth in the direct-to-consumer (DTC) genetic testing market.

Market Key Players

Various key players are discussed in this report such as Shuwen Health Sciences, Canadian DNA Services, DNA Services of America, DNA Diagnostics Center, Sure Genomics, Walk-in-Lab, Alpha Biolaboratories, MapMyGenome, Positive Bioscience, Kailos Genetics, Gene by Gene, Genomics Express, DirectLabs, DNA4Life, and 23andMe.

Market Taxonomy

By Test Type

• Carrier Screening Tests
• Genetic Health Risk (GHR) Tests
• Pharmacogenetics Tests
• Cancer Predisposition Tests
• Low Risk General Wellness Tests
• Ancestry Tests
• Paternity Testing
• Cancer Susceptibility Tests